North Dakota State Investment Board acquired a new stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 5,198 shares of the technology company’s stock, valued at approximately $1,160,000.
Other large investors have also recently added to or reduced their stakes in the company. Jensen Investment Management Inc. boosted its holdings in Veeva Systems by 1,924.5% during the third quarter. Jensen Investment Management Inc. now owns 413,213 shares of the technology company’s stock worth $123,100,000 after buying an additional 392,802 shares in the last quarter. Alphinity Investment Management Pty Ltd acquired a new position in Veeva Systems in the 3rd quarter worth approximately $422,241,000. Principal Financial Group Inc. boosted its stake in Veeva Systems by 11.2% in the 3rd quarter. Principal Financial Group Inc. now owns 3,846,877 shares of the technology company’s stock worth $1,146,040,000 after purchasing an additional 388,864 shares during the period. Compass Wealth Management LLC acquired a new position in Veeva Systems in the 3rd quarter worth approximately $18,694,000. Finally, ABN AMRO Bank N.V. acquired a new position in Veeva Systems in the 3rd quarter worth approximately $246,625,000. 88.20% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
VEEV has been the subject of a number of recent analyst reports. Wells Fargo & Company decreased their price objective on shares of Veeva Systems from $333.00 to $317.00 and set an “overweight” rating for the company in a research note on Thursday, March 5th. William Blair reaffirmed an “outperform” rating on shares of Veeva Systems in a research note on Tuesday, March 10th. Zacks Research lowered shares of Veeva Systems from a “strong-buy” rating to a “hold” rating in a research note on Thursday, May 14th. Barclays decreased their price objective on shares of Veeva Systems from $305.00 to $250.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Finally, UBS Group raised their price objective on shares of Veeva Systems from $200.00 to $220.00 and gave the stock a “neutral” rating in a research note on Thursday, March 5th. Sixteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $276.52.
Key Headlines Impacting Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Investor sentiment improved after Michael Burry was reported to hold a position in Veeva Systems, adding a high-profile endorsement for the stock. Veeva Systems Inc. (VEEV): Michael Burry Admires This Software Stock
- Positive Sentiment: Multiple articles highlighted Veeva’s RTSM momentum, major pharma wins, and durable long-term growth drivers in clinical software, reinforcing the bull case for the business. Veeva Systems’ RTSM Momentum Signals Another Long-Term Growth Driver
- Positive Sentiment: Coverage also framed Veeva as a strong growth stock with healthy fundamentals and long-term investor appeal, which can help support the shares. Here's Why Veeva Systems (VEEV) is a Strong Growth Stock
- Neutral Sentiment: Another article repeated the argument that Veeva has strong long-term growth potential and is attracting institutional interest, but it was largely reiterative rather than a new catalyst. Long-Term Growth Potential Driving Investor Interest In Veeva Systems Inc. (VEEV)
- Neutral Sentiment: Analyst commentary remained generally optimistic overall, though one report noted Oppenheimer trimmed its price target to $225, which may limit enthusiasm somewhat. Veeva Systems (NYSE:VEEV) Price Target Lowered to $225.00 at Oppenheimer
- Negative Sentiment: One market recap said Veeva rose but still lagged the broader market, suggesting the move may reflect cautious trading rather than a decisive breakout. Veeva Systems (VEEV) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Veeva Systems Stock Up 1.1%
VEEV stock opened at $165.10 on Thursday. Veeva Systems Inc. has a 12-month low of $148.05 and a 12-month high of $310.50. The company has a market cap of $26.96 billion, a price-to-earnings ratio of 30.52, a PEG ratio of 0.73 and a beta of 0.92. The company has a 50 day moving average of $169.55 and a two-hundred day moving average of $205.57.
Veeva Systems (NYSE:VEEV – Get Free Report) last released its earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Veeva Systems had a net margin of 28.44% and a return on equity of 13.80%. The company had revenue of $835.95 million during the quarter, compared to the consensus estimate of $810.95 million. During the same quarter in the prior year, the firm earned $1.74 EPS. The company’s revenue was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, research analysts anticipate that Veeva Systems Inc. will post 6.41 EPS for the current year.
Insider Transactions at Veeva Systems
In other news, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction on Thursday, April 30th. The shares were sold at an average price of $155.64, for a total transaction of $116,730.00. Following the transaction, the director owned 3,253 shares in the company, valued at approximately $506,296.92. This trade represents a 18.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by insiders.
Veeva Systems Company Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Stories
- Five stocks we like better than Veeva Systems
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
